[103] conducted a glycolytic stress assay, revealing that glycolysis levels decreased, while glycolytic reserve levels were notably downregulated in the HCT116 and HT29 CRC cell lines following FASN inhibition. The gene discussed is FASN; the disease is colorectal carcinoma.